ArticlePlant physiology2026
The NAD salvage pathway enzyme NMNAT-C sustains dark-phase NAD+ homeostasis in cyanobacteria.
Article in Plant physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Focus on algae and aquatic plants.Plant physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Nicotinamide adenine dinucleotide (NAD+) is a crucial cofactor in cyanobacteria, which serve as model organisms for studying photosynthesis. Maintaining NAD+ homeostasis in cyanobacteria is critically important, and it is currently believed that multiple pathways contribute to NAD+ biosynthesis in these organisms. However, the specific contribution of each pathway to NAD+ supplementation under both light and dark conditions, which determines NAD+ homeostasis, has not yet been studied. In this study, we identified NMNAT-C, a cyanobacterial nicotinamide nucleotide adenylyltransferase (NMNAT), as a key player in NAD+ homeostasis, particularly during dark phases. NMNAT-C showed opposite-phase oscillations in expression, aligned with NAD+ fluctuations during light-dark cycles. Genetic and biochemical tests revealed that deleting NMNAT-C in one cyanobacterium (Synechococcus elongatus PCC 7942) accelerated NAD+ depletion during dark periods, increased sensitivity to dark stress, and impacted growth rate. Conversely, induced overexpression of NMNAT-C temporarily raised NAD+ levels but also caused adverse effects over time. Metabolomic analysis indicated that NMNAT-C plays a role in mediating the metabolic crosstalk between the NAD+ salvage pathway and the de novo pathway. Our results identify NMNAT-C as a key regulator of NAD+ dynamics that aligns with daily cycles and suggest that this enzyme plays a crucial role in maintaining NAD+ homeostasis through the NAD+ salvage pathway.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.